In an exploratory 48-week extension of EXPLORER-CN (79 Chinese patients with obstructive HCM), mavacamten through week 78 was associated with maintained falls in Valsalva LVOT gradient (mean −73.0 mm Hg) and appeared well tolerated; descriptive analysis only.
RCTn = 79
Tian et al. Long-Term Efficacy and Safety of Mavacamten in Chinese Patients With Obstructive Hypertrophic Cardiomyopathy: Week 78 Results From the EXPLORER-CN Study